A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9–15 PROMISE-meso phase III trial

Autor: Banna, Giuseppe Luigi, Addeo, Alfredo, Zygoura, Panagiota, Tsourti, Zoi, Popat, Sanjay, Curioni-Fontecedro, Alessandra, Nadal, Ernest, Shah, Riyaz, Pope, Anthony, Fisher, Patricia, Spicer, James, Roy, Amy, Gilligan, David, Gautschi, Oliver, Janthur, Wolf-Dieter, López-Castro, Rafael, Roschitzki-Voser, Heidi, Dafni, Urania, Peters, Solange, Stahel, Rolf A.
Zdroj: In Lung Cancer July 2022 169:77-83
Databáze: ScienceDirect
Externí odkaz: